Andrew is a co-founder of KalVista Pharmaceuticals and its CEO. Prior to KalVista, Andrew held various senior management positions including chief executive, vice president of business development and director of clinical and regulatory affairs in biotech and specialty pharmaceutical companies in the United States and United Kingdom. During his career he has identified, negotiated and executed strategic corporate transactions on a global basis, including merger and acquisitions, national and international product licenses, IP and technology licenses, and R&D alliances.
Andrew received a BA from the University of Utah, and MBA from The Wharton School, University of Pennsylvania, with a major in Finance.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.